Description

4-(Dimethylamino)-3-((dimethylamino)methylene)-1,3-dihydro-2H-1,5-benzodiazepin-2-one is a high-purity, specialized organic compound belonging to the benzodiazepine class, serving as a critical advanced intermediate in pharmaceutical synthesis. Its unique molecular structure, featuring dual dimethylamino groups, makes it a valuable building block for creating complex active pharmaceutical ingredients (APIs) and fine chemicals. This product is essential for research and development laboratories, custom synthesis operations, and manufacturers within the pharmaceutical and agrochemical industries seeking reliable, high-quality intermediates.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel benzodiazepine-based therapeutic agents and other complex heterocyclic compounds.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the development of new drug candidates targeting the central nervous system (CNS).
• Custom Synthesis: Employed by contract research and manufacturing organizations (CROs/CMOs) for the production of bespoke molecules and advanced intermediates for clients.
• Agrochemical Research: Serves as a building block in the development of new pesticides and herbicides with specific biological activity.
• Chemical Reference Standard: Utilized as a high-purity standard for analytical method development, validation, and quality control in laboratories.

Basic Information

Item	Detail
Product Name	4-(Dimethylamino)-3-((dimethylamino)methylene)-1,3-dihydro-2H-1,5-benzodiazepin-2-one
CAS No.	87295-93-0
Molecular Formula	C₁₄H₁₈N₄O
Molecular Weight	258.32 g/mol
Synonyms	2H-1,5-Benzodiazepin-2-one, 4-(dimethylamino)-3-[(dimethylamino)methylene]-1,3-dihydro-; 3-((Dimethylamino)methylene)-4-(dimethylamino)-1,3-dihydro-2H-1,5-benzodiazepin-2-one; 4-Dimethylamino-3-((dimethylamino)methylene)-1,3-dihydro-2H-1,5-benzodiazepin-2-one; CAS 87295-93-0; Benzodiazepine derivative intermediate
EINECS	Contact for details

Quality Control

Our production of 4-(Dimethylamino)-3-((dimethylamino)methylene)-1,3-dihydro-2H-1,5-benzodiazepin-2-one adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and tests for residual solvents and moisture content. We provide a detailed Certificate of Analysis (COA) with each shipment, ensuring traceability and compliance with your specifications and relevant industry standards.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Yellow to light brown crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals (as Pb)	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.